The creatinine-to-cystatin C ratio as a prognostic risk-stratification biomarker in chronic kidney disease
Frontiers in Nutrition · 09.03.2026 · 13
DOI: 10.3389/fnut.2026.1766312 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 09.03.2026. Verfasst von Xiaohong Zeng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, Ganzhou People's Hospital, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganz…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The creatinine-to-cystatin C ratio (Cr/CysC) is a promising surrogate marker for muscle mass. While associated with adverse outcomes in various diseases, its prognostic utility for cardiorenal risks in the Chinese non-dialysis chronic kidney disease (CKD) population remains inadequately explored. This study aimed to investigate the association between the Cr/CysC ratio and the risks of cardiovascular disease (CVD) and CKD progression in a large Chinese CKD cohort.
Methods
We conducted a retrospective cohort study of 16,031 non-dialysis CKD patients from the China Renal Data System (CRDS). Cox proportional hazards models were used to assess the relationship between the serum Cr/CysC ratio and the incidence of CVD and CKD progression over 28,189.68 person-years of follow-up.
Results
In CKD patients, a higher serum Cr/CysC ratio was significantly associated with lower risks of both CVD events and CKD progression. Compared to the lowest quartile (Q1), patients in the highest quartile (Q4) had a 21% lower risk of CVD (HR: 0.79, 95% CI: 0.67–0.92) and a 49% lower risk of CKD progression (HR: 0.51, 95% CI: 0.46–0.58). When analyzed as a continuous variable, each unit increase in the log-transformed ratio was associated with a significantly reduced risk for both outcomes ( p < 0.001).
Conclusion
A higher serum Cr/CysC ratio is independently associated with reduced risks of CVD and CKD progression in Chinese patients with non-dialysis CKD. This ratio may serves as a useful prognostic marker for risk stratification in this population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, Ganzhou People's Hospital, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, China.
- Department of Nephrology, Ganzhou People's Hospital, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, China.
- Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney and Urological Diseases, Nanfang Hospital, State Key Laboratory of Multi-organ Injury Prevention and Tr…
Zitieren
APA
Zeng, X., Liu, D., Su, L., Wang, M., Yang, G., Liang, M., & Peng, Z. (2026). The creatinine-to-cystatin C ratio as a prognostic risk-stratification biomarker in chronic kidney disease. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1766312
Vancouver
Zeng X, Liu D, Su L, Wang M, Yang G, Liang M, et al. The creatinine-to-cystatin C ratio as a prognostic risk-stratification biomarker in chronic kidney disease. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1766312
BibTeX
@article{Zeng2026,
author = {Zeng, Xiaohong and Liu, Dehui and Su, Licong and Wang, Meihua and Yang, Guang and Liang, Min and Peng, Zhiqiang},
title = {The creatinine-to-cystatin C ratio as a prognostic risk-stratification biomarker in chronic kidney disease},
journal = {Frontiers in Nutrition},
year = {2026},
volume = {13},
doi = {10.3389/fnut.2026.1766312}
}
EUVIMED